← SynDRA

BRIVANIB ALANINATE

SynDRA canonical compound SYN0009250 — structure-anchored drug synonym record

Clinical phasePhase 3
Primary target(s)FGFR1 | FGFR3 | FLT1 | KDR
Mechanism of actionFGFR inhibitor | VEGFR inhibitor

All known targets

Mechanisms of action (all sources)

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

Cross-references

Synonyms

Look up BRIVANIB ALANINATE in the interactive SynDRA portal →